Cancer Rewrites the Self: How Young Survivors Rebuild Identity, and Why LGBTQ+ Patients Face Extra Hurdles

A cancer diagnosis between the ages of 15 and 39 strikes at the very moment life is supposed to be assembling itself. Careers are launched, relationships form, bodies change, and worldviews harden into something like a stable sense of self. When a team of researchers at Memorial Sloan Kettering Cancer Center set out to understand what cancer does to that fragile, fast-moving process of identity formation, they uncovered a picture that is at once deeply personal and clinically urgent. Their study, published in Supportive Care in Cancer, offers one of the most detailed qualitative maps to date of how a cancer diagnosis and its treatment reshape who young survivors believe they are, and it reveals a layer of experience that has been almost entirely missing from the literature: the distinct challenges faced by sexual and gender minority (SGM) survivors.

The research, led by Marie E. Barnett, Rebecca C. Tutino, and colleagues in the Department of Psychiatry and Behavioral Sciences, took an unusual methodological route. Rather than designing a new study from scratch, the team conducted a secondary qualitative analysis of six focus groups that had originally been convened to guide the development of an adolescent and young adult (AYA) cancer program. Those focus groups captured survivors between the ages of 15 and 39 speaking candidly about their experiences. The researchers then applied a grounded theory approach, a qualitative technique in which codes and concepts are built up systematically from the data itself rather than imposed from a pre-existing hypothesis. Using NVivo software, they coded the transcripts iteratively, allowing themes to emerge from the survivors’ own words, and from that process they constructed a novel conceptual framework of AYA identity after cancer.

The central finding is that identity in this age group is not disturbed by cancer in a single way. Instead, the analysis identified three interrelated domains of change, physical, psychological, and social, that interact with one another and evolve together across the cancer trajectory. Physical changes include the visible and invisible alterations wrought by surgery, chemotherapy, and radiation: scars, hair loss, fatigue, fertility impairment, and long-term functional limitations. Psychological changes encompass shifts in self-esteem, body image, and the survivor’s sense of a predictable future. Social changes involve renegotiated relationships with family and friends, disrupted education and employment, and the often jarring experience of being out of step with peers who are moving through ordinary developmental milestones. The framework’s key insight is that these domains do not operate in isolation; a surgical scar is simultaneously a physical mark, a psychological wound to body image, and a social signal that must be explained, hidden, or displayed.

This integrated view echoes a long tradition in developmental psychology. Erik Erikson described identity formation as the central psychosocial task of adolescence and young adulthood, and Jeffrey Arnett’s concept of emerging adulthood characterizes the late teens and twenties as a period of exploration and instability. Cancer interrupts precisely that exploration. Prior quantitative work has shown that young adults diagnosed with cancer report elevated psychological distress compared with matched peers, and that fears about disease recurrence and early death can shadow survivors for years. What the new study adds is a granular, survivor-centered account of the mechanisms: how a delayed college graduation or a forced career pivot feeds into a revised sense of competence, how altered fertility reframes imagined family futures, and how the label of patient or survivor can compete with, and sometimes overwhelm, other identities the young person was still building.

Layered onto this general picture, the researchers found a set of experiences that were unique to sexual and gender minority survivors. SGM participants described navigating heteronormative assumptions within healthcare settings, the pervasive expectation by clinicians and staff that patients are heterosexual and cisgender. Forms that offered only binary gender options, intake questions that presumed a male partner or a husband, and casual remarks that erased a patient’s partner or identity all forced SGM survivors into a recurring decision: whether to disclose, correct, or stay silent. Each disclosure carries its own cognitive and emotional load, and each silence can leave a survivor feeling unseen in the very environment where they are most vulnerable. The study’s framework positions these navigation and disclosure experiences as surrounding the core physical, psychological, and social changes, adding an extra layer of identity work that heterosexual survivors simply do not face.

That extra layer matters because the broader evidence base already documents disparities for SGM patients across the cancer continuum. Scoping reviews have found gaps in care delivery, patient experience, and health outcomes for sexual and gender minority patients with cancer, and studies of NCI-designated comprehensive cancer centers have used sexual orientation and gender identity data to reveal real-world differences in cancer burden. Research on lesbian and bisexual women with breast cancer, gay and bisexual men at risk for HPV-related disease, and transgender populations has repeatedly pointed to barriers in screening, communication, and survivorship support. Psychological distress appears elevated among SGM cancer survivors compared with their heterosexual counterparts, and minority stress theory, developed by Ilan Meyer, provides a mechanistic explanation: chronic exposure to stigma, discrimination, and concealment produces a physiological and psychological stress burden with measurable health consequences. The new study extends this line of inquiry into the developmental heart of the AYA period, where identity is still under construction and the stakes of feeling invisible are arguably at their highest.

The clinical implications of the framework are concrete. The authors argue that clinicians need greater awareness of how a cancer diagnosis and its treatment shape AYA identities, not merely how they shape tumors and symptoms. A survivor’s refusal to adhere to a follow-up regimen, their disengagement from rehabilitation, or their anxiety about returning to work may all be legible through the lens of identity disruption. The study points toward increased support structures, including psychological intervention and peer support groups, as practical responses. Peer support carries particular weight in the AYA context because the developmental isolation of being a young person on an oncology ward designed for older adults, or in a pediatric ward designed for children, is itself an identity stressor. Connecting survivors with others navigating the same life stage can normalize the renegotiation of self that the framework describes.

For SGM survivors specifically, the findings argue for structural changes in cancer care: routine and respectful collection of sexual orientation and gender identity information, training that equips oncology providers to avoid heteronormative assumptions, and survivorship programs that do not presume a heterosexual family structure when discussing fertility, relationships, or caregiver support. The American Society of Clinical Oncology has issued position statements on reducing cancer health disparities among SGM populations, and studies of culturally competent care at major cancer centers suggest that institutional commitment, not just individual goodwill, determines whether SGM patients experience affirmation or erasure. The new framework gives these efforts a developmental rationale: for a young SGM survivor, an affirming clinical environment is not a courtesy but a component of identity-safe cancer care.

The study’s limitations are those inherent to its design. It is an exploratory, qualitative analysis of focus groups conducted for a different primary purpose, at a single academic cancer center, and the authors note that further research is warranted to understand the needs of SGM AYA survivors in particular. Qualitative work of this kind does not measure prevalence; it maps meaning. Yet that mapping is precisely what has been missing. By grounding a conceptual framework in the actual language of young survivors, the Memorial Sloan Kettering team has given clinicians, program designers, and researchers a shared vocabulary for a phenomenon that survivors have long described but medicine has rarely named: the way cancer, arriving in the years when the self is still being written, forces a rewrite, and the way that rewrite is harder, and lonelier, for those who must also fight to be seen as themselves.

Subject of Research: Identity formation and its disruption among adolescent and young adult cancer survivors, including sexual and gender minority experiences

Article Title: Identity among adolescent and young adult cancer survivors: an exploratory qualitative study

Article References: Identity among adolescent and young adult cancer survivors: an exploratory qualitative study. (n.d.). https://doi.org/10.1007/s00520-026-11158-z

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11158-z

Keywords: adolescent and young adult oncology, cancer survivors, identity formation, sexual and gender minorities, qualitative research, grounded theory, psychosocial oncology, survivorship care, minority stress, body image, peer support, health disparities